QQ客服 官方微博 反馈留言

	Levistolide A synergistically enhances doxorubicin-induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway
	Ding, Yuanyuan; Niu, Weibo; Zhang, Tao; Wang, Jue; Cao, Jiao; Chen, He; Wang, Ruiqi; An, Hongli
刊名	ONCOLOGY REPORTS
	2019
卷号	41期号:2页码:1198-1208
关键词	chemotherapeutic drugs multidrug resistance levistolide A downregulation MDR1
DOI	10.3892/or.2018.6889
URL标识	查看原文
公开日期	[db:dc_date_available]
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/4561397
专题	山东大学
作者单位	Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Translat Med, 277 Yanta West Rd, Xian 710061, Shaanxi
推荐引用方式 GB/T 7714	Ding, Yuanyuan,Niu, Weibo,Zhang, Tao,et al. Levistolide A synergistically enhances doxorubicin-induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway[J]. ONCOLOGY REPORTS,2019,41(2):1198-1208.
APA	Ding, Yuanyuan.,Niu, Weibo.,Zhang, Tao.,Wang, Jue.,Cao, Jiao.,...&An, Hongli.(2019).Levistolide A synergistically enhances doxorubicin-induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway.ONCOLOGY REPORTS,41(2),1198-1208.
MLA	Ding, Yuanyuan,et al."Levistolide A synergistically enhances doxorubicin-induced apoptosis of k562/dox cells by decreasing MDR1 expression through the ubiquitin pathway".ONCOLOGY REPORTS 41.2(2019):1198-1208.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。